Ennaid Therapeutics is a global biopharmaceutical company using its unique, patented platform technology to safely and rapidly develop and commercialize therapeutics for infectious diseases. The Company’s lead compound, ETX-101, is an inhibitory peptide that inhibits all four strains of dengue…
Finance: Commercial Banking, Lending, Underwriting
No mentions listed yet.
No one has curated this page yet. Be the first.
Curate